U.S. Markets closed

Cipla Limited (CIPLA.NS)

NSE - NSE Real Time Price. Currency in INR
Add to watchlist
565.30-7.90 (-1.38%)
At close: 3:29PM IST

Cipla Limited

Cipla House
Peninsula Business Park
Mumbai 400013
India
91 22 2482 6000
http://www.cipla.com

SectorHealthcare
IndustryDrug Manufacturers - Major
Full Time Employees

Key Executives

NameTitlePayExercisedAge
Mr. Umang Vohra B.E., M.B.A.MD, Global CEO & Director136.6MN/A46
Mrs. Samina VaziralliExec. Vice Chairperson and Global Head of Strategy, M&A, New Ventures & Key Partner Relationships39MN/A41
Mr. Kedar Upadhye B.Com., AICWA, CS, MBAGlobal Chief Financial Officer31.3MN/A40
Mr. Rajendra ChopraCompliance Officer & Company Sec.2.4MN/AN/A
Mr. Prabir Kumar Jha M.A., P.G.D.M.Global Chief People OfficerN/AN/A50
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Cipla Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India. It offers active pharmaceutical ingredients; and formulations in various therapeutic areas, such as women’s health, cardiovascular, children’s health, dermatology and cosmeceuticals, diabetes, HIV-AIDS, hepatitis, oncology, infectious diseases and critical care, malaria, neurosciences, ophthalmology, osteoporosis, respiratory, and urology. The company also provides veterinary products, including anti-infectives, anti-inflammatories, anti-thyroids, immunosuppressants, parasiticides, nutraceuticals, and feed additives for various animals, including equine and companion care, livestock, poultry, swine, and aqua products. In addition, it offers inhalation therapy devices comprising metered-dose inhalers, dry powder inhalers, nasal sprays, nebulizers, and inhalation accessory devices, as well as spacers and related devices. The company also exports its products to Africa, the Middle East, Latin America, the Asia Pacific, North America, Australia, New Zealand, Russia, and internationally. Cipla Limited was founded in 1935 and is based in Mumbai, India.

Corporate Governance

Cipla Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.